Skip to content

Medicinova Inc

MNOV· NasdaqCore metricsCIK 1226616

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +0.36%
Market cap
$71.98M
51.23M shares
Filings
881
$138.56K
Q3 2026−59.0% FY25 yoy
-$2.84M
Q3 2026N/M FY25 yoy
-$3.06M
Q3 2026N/M FY25 yoy
-$7.79M
Q3 2026derivedN/M FY25 yoy
-$0.06
Q3 2026N/M FY25 yoy
$29.26M
Q3 2026−23.7% FY25 yoy
$71.98M
—
175.7×
1.8×
-13.63%
—

FY2025 figures · derived

Price

$1.4112.73%$0.21past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$409.66KFY 2025
$4.04M0FY 2012FY 2021FY 2023FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$409,657reported
FY 20232023-12-31$1,000,000reported
FY 20212021-12-31$4,037,500reported
FY 20122012-12-31$802,580reported

Capital returns

Dividends and buybacks · FY2009 to FY2012
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2012—$58.62K$58.62K—18.24M sh+13.4%—
FY2011—$8.23K$8.23K—16.09M sh+29.3%—
FY2010—$37.46K$37.46K—12.44M sh——
FY2009—$81.97K$81.97K————

Pharmaceutical preparations

Medicinova Inc is the 230th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR